Trademark: 79341296
Status Date
Tuesday, April 25, 2023
Registration Number
7033292
Registration Date
Tuesday, April 25, 2023
Filing Date
Monday, March 7, 2022
Published for Opposition
Tuesday, February 7, 2023
5 Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
10 Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for use in hematology and in tissue and organ transplantation; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of kidney diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diabetes; medical apparatus and instruments for the diagnosis, prevention and treatment of hypertension; medical apparatus and instruments for the diagnosis, prevention and treatment of skin disorders; medical apparatus and instruments for use in urology; medical apparatus and instruments for ophthalmological use; medical apparatus and instruments for the diagnosis, prevention and treatment of cancer and tumors; medical apparatus and instruments for the diagnosis, prevention and treatment of allergies; medical apparatus and instruments for the diagnosis, prevention and treatment of bone diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of respiratory diseases and asthma; radiological apparatus and instruments for medical use in the nature of radiological apparatus for medical purposes; genetic testing apparatus and instruments for medical use in the nature of genetic testing apparatus for medical purposes; electromagnetic drug delivery apparatus and instruments for medical use in the nature of electromagnetic drug delivery apparatus for medical use; medical apparatus and instruments for diagnostic radiopharmaceutical use; medical apparatus and instruments for facilitating the inhalation of pharmaceutical preparations in the nature of medical apparatus for facilitating the inhalation of pharmaceutical preparations; apparatus and instruments for DNA and RNA testing for medical use in the nature of apparatus for DNA and RNA testing for medical purposes; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and instruments for introducing pharmaceutical preparations into the human body in the nature of medical apparatus for introducing pharmaceutical preparations into the human body
The mark consists of a design featuring a shaded square design with two transparent and shaded outlined chevron designs that are featured on top of the shaded square design. The colors black, grey, and white represent background, outlining, shading, and transparent areas and are not claimed as features of the mark.
Aug 4, 2023
Final Disposition Notice Sent To Ib
Aug 4, 2023
Final Disposition Processed
Jul 25, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 25, 2023
Notice Of Registration Confirmation Emailed
Apr 25, 2023
Registered-Principal Register
Feb 7, 2023
Notification Processed By Ib
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Possible Opposition Sent To Ib
Jan 18, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 3, 2023
Approved For Pub - Principal Register
Dec 1, 2022
Teas/Email Correspondence Entered
Dec 1, 2022
Correspondence Received In Law Office
Dec 1, 2022
Teas Response To Office Action Received
Nov 25, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 25, 2022
Teas Change Of Correspondence Received
Nov 25, 2022
Teas Change Of Domestic Representatives Address
Nov 25, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 25, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 25, 2022
Teas Change Of Owner Address Received
Sep 27, 2022
Refusal Processed By Ib
Sep 2, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Sep 1, 2022
Refusal Processed By Mpu
Aug 3, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Aug 2, 2022
Non-Final Action Written
Aug 2, 2022
Assigned To Examiner
Jun 11, 2022
Application Filing Receipt Mailed
Jun 7, 2022
New Application Office Supplied Data Entered
Jun 6, 2022
Limitation From Original Application Entered
May 26, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
